A study involving ten European countries, including Switzerland, has been launched to better understand monkeypox. It will follow people affected by the disease, record their symptoms and study their response to treatment.
This content was published on
2 minutes
Keystone-SDA/ts
Español
es
Suiza recluta pacientes para estudio de la viruela del mono
The Geneva University Hospitals (HUG) said it had recruited its first three patients.
The study builds on ongoing work in the Central African Republic to better characterise the disease in countries where recent spread has been reported. For the moment Switzerland is the first country to recruit patients for the study. The aim is to extend it to as many countries as possible.
“Thanks to this unprecedented international collaboration, we will be able to contribute to a better understanding of the disease and thus to adjust our response in the fight against it,” said Alexandra Calmy, head of the HIV/AIDS Unit at the HUG.
At least 500 patients are expected to be included in the study, she added. To date, ten countries have announced their participation: Switzerland, the UK, Belgium, France, Ireland, Italy, the Netherlands, Norway, Portugal and Spain.
Rarely fatal
Monkeypox is a relatively rare disease. It usually causes a painful rash but is rarely fatal. It was discovered in the late 1950s, with outbreaks occurring in communities in central and western Africa. The disease is now spreading to Europe.
More than 50 countries where monkeypox is not endemic have reported outbreaks of the viral disease as confirmed cases exceed 7,600. Switzerland had 140 confirmed cases as of July 8.
In Switzerland, as elsewhere in Europe, the population most affected by the disease comprises young men who are involved in “dense sexual networks” and in particular who report having gay sex, Calmy said.
More
More
South Africa confirms third monkeypox case in tourist from Switzerland
This content was published on
South Africa has confirmed a third case of monkeypox, in a 42-year-old male tourist from Switzerland.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
This content was published on
The second case of monkeypox in Switzerland was detected in a person in Geneva, who was contaminated during a trip abroad.
Monkeypox medication not authorised in Switzerland
This content was published on
Tecovirimat and the latest smallpox vaccine, which help against monkeypox, are not available in Switzerland, the NZZ am Sonntag reports.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.